PVLA · Palvella Therapeutics, Inc. · Investor Relations

$124.83 +1.87 (+1.52%)

Russell 2000 member Rebalance outlook locked

Market Cap

$1.77B

14.41M

Volume · Oct 20 174.42K Avg daily vol (3M) 212.9K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-10-20	Chardan 10th Annual Healthcare Conference	Conference
2026-09-15	H.C. Wainwright 28th Annual Global Investment Conference	Conference
2026-09-09	Cantor Global Healthcare Conference 2026	Conference
2026-08-12	Canaccord Genuity 46th Annual Growth Conference	Conference
2026-08-04	Q2 FY2026 Earnings conference call (announced in 8-K)	Earnings call
2026-06-09	Goldman Sachs 47th Annual Global Healthcare Conference	Conference
2026-05-07	Q1 FY2026 Earnings conference call (announced in 8-K)	Earnings call
2026-03-31	Earnings conference call (announced in 8-K)	Earnings call
2026-02-24	Palvella Therapeutics Conference Call to Discuss Topline Results from the Phase 3 SELVA Study	Earnings call
2025-12-15	Palvella Therapeutics Conference Call to Discuss Topline Results from the Phase 2 TOIVA study	Earnings call
2025-11-12	Stifel 2025 Healthcare Conference	Conference
2025-11-11	Palvella’s Third Quarter 2025 Financial Results and Corporate Update Conference Call	Earnings call
2025-11-05	Palvella Therapeutics Conference Call to Discuss New Product Candidate QTORIN™ Pitavastatin for Disseminated Superficial Actinic Porokeratosis	Conference
2025-09-24	Palvella Therapeutics Conference Call to Discuss Expansion of QTORIN™ Rapamycin Pipeline to Include Clinically Significant Angiokeratomas	Conference

Source: https://ir.palvellatx.com/

Key facts CIK 1583648 CUSIP 697947109 13F (30d) 13 filings 13 filers Visit website Investor relations